RUSCH Endotracheal Tube oral/nasal Magill, High Volume, Low Pressure Cuff, REF numbers: a) 11208...
FDA Device Recall #Z-2321-2021 — Class II — July 16, 2021
Recall Summary
| Recall Number | Z-2321-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 16, 2021 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Teleflex Medical Europe Ltd |
| Location | Athlone, N/A |
| Product Type | Devices |
| Quantity | 2610 units |
Product Description
RUSCH Endotracheal Tube oral/nasal Magill, High Volume, Low Pressure Cuff, REF numbers: a) 112080050 b) 112080055 c) 112080060 d) 112080065 e) 112080070 f) 112080075 g) 112080080 h) 112080085 i) 112080090 j) 112080095 k) 112080100
Reason for Recall
The firm received reports that the endotracheal tube cuff could be inflated while the pilot balloon remained flat.
Distribution Pattern
US Nationwide distribution.
Lot / Code Information
a) 112080050, Lot Numbers: KME20K1512, KME20L1145, KME20M2383, KME21B0357 b) 112080055, Lot Numbers: KME20K2579, KME21A2569, KME21C1978 c) 112080060, Lot Numbers: KME20M0616, KME20M2112, KME21A2685 d) 112080065, Lot Numbers: KME20K2581, KME21C1701 e) 112080070, Lot Numbers: KME20K2577, KME20L1985, KME20M1771, KME20M1772, KME20M2856, KME21A2355, KME21B1624, KME21B2490, KME21C1184 f) 112080075, Lot Numbers: KME20K0110 g) 112080080, Lot Numbers: KME20M0377, KME21B2727, KME21C0500 h) 112080085, Lot Numbers: KME20M0909, KME21B0519, KME21C0067 i) 112080090, Lot Numbers: KME20K1808, KME20L2352, KME20M2248 j) 112080095, Lot Numbers: KME20K2310, KME20L1153 k) 112080100 Lot Numbers: KME20K1005, KME20L1144
Other Recalls from Teleflex Medical Europe Ltd
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2319-2021 | Class II | RUSCH Slick Set Cuffed Endotracheal Tube and St... | Jul 16, 2021 |
| Z-2322-2021 | Class II | RUSCH Endotracheal Tube oral/nasal Murphy Eye, ... | Jul 16, 2021 |
| Z-2320-2021 | Class II | RUSCH Flexi-Set Cuffed Endotracheal Tube and St... | Jul 16, 2021 |
| Z-2287-2018 | Class II | Teleflex MEDICAL Pilling(R) UNIVERSAL SHEARS 7 ... | Jun 12, 2018 |
| Z-1403-2018 | Class II | Teleflex MEDICAL HUDSON RCI One Way Valve w. Ca... | Mar 27, 2018 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.